News | SummitMD

AVATAR Makes Case for Early Surgery Over Watchful Waiting in Asymptomatic Severe AS

Adding to RECOVERY findings, AVATAR confirms early SAVR lowers MACE rates in very severe AS

January 07, 2022 53940 0 Read More

News | SummitMD

4 Takeaways from the 2021 ESC/EACTS Guideline for Valvular Heart Disease

New updates include timing of intervention, TAVR vs. SAVR selection criteria, surgery priority over TEER for MR, and anticoagulation strategies for VHD subgroups

November 17, 2021 72136 0 Read More

News | SummitMD

Rushing Angiography for OHCA Patients without ST-Segment Elevation Largely Unbeneficial

TOMAHAWK investigators stress importance of selective and thorough process for angio for better outcomes

November 04, 2021 4872 0 Read More

News | SummitMD

Edoxaban Trial Paints Fragmented Picture for Doacs in AF-TAVR: ENVISAGE-TAVI AF

Edoxaban noninferior to VKA for adverse events but carries higher bleeding risk

October 21, 2021 2519 0 Read More

News | SummitMD

1-Month DAPT in High-Bleeding Risk Noninferior for Ischemic Outcomes, Less Bleeding: MASTER-DAPT

In HBR patients after DES-PCI, shorter 1-month DAPT showed noninferior NACE/MACCE rates with less major bleeds compared to 12-month DAPT

October 06, 2021 15375 0 Read More

News | SummitMD

FLOWER-MI: FFR Shows No Benefit over Angio for Complete Revasc in Multi-vessel STEMIs

Findings say FFR-guided PCI not superior (or cost-effective) compared to angio-guided PCI, although experts warn results may not be conclusive

July 21, 2021 12062 0 Read More

News | SummitMD

'Next-Gen' ADAPTABLE Study Says Low-Dose Aspirin Equal to High-Dose for ASCVD Patients

High-tech, low-cost study reflects real-world data and finds 81mg aspirin superior, although critics say high switching rate impacts reliability of findings

July 05, 2021 2860 0 Read More